Beyond the conventional focus on amyloid protein and tau abnormalities, researchers are increasingly discovering novel pharmacological avenues for Alzheimer's condition. These feature affecting brain inflammation through reducing microglial activation, modifying neural connection impairment – particularly associated with excitatory neurotransmitt